Related Experiment Video
Updated: Jul 24, 2026

Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter
Published on: August 12, 2021
Direct on-the-spot detection of SARS-CoV-2 in patients
Nadav Ben-Assa1, Rawi Naddaf1, Tal Gefen1
1Department of Cell Biology and Cancer Science, Technion Integrated Cancer Center (TICC),Rappaport Faculty of Medicine, Technion-Institute of Technology, Haifa 3525433, Israel.
Impact Statement:
Humanity is currently experiencing a global pandemic with devastating implications on human health and the economy. Most countries are gradually exiting their lockdown state. We are currently lacking rapid and simple viral detections, especially methods that can be performed in the household. Here, we applied RT-LAMP directly on human clinical swabs and self-collected saliva samples. We adjusted the method to allow simple and rapid viral detection, with no RNA purification steps. By testing our method on over 180 human samples, we determined its sensitivity, and by applying it to other viruses, we determined its specificity. We believe this method has a promising potential to be applied world-wide as a simple and cheap surveillance test for SARS-CoV-2.
Related Concept Videos
Rapid Identification of Pathogens
Coronavirus

